MedTrace Logo

A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)

NCT00347594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2014-01-17

No results posted yet for this study

Summary

The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.

Conditions

  • Healthy

Interventions

DEVICE

Next Generation Diagnostic Instrument (NGDI)

Measurement of the aberrations, corneal surface topography, and pachymetry of normal human eyes

DEVICE

Zyoptix Diagnostic Workstation (ZDW)

Measurement of the aberrations, corneal surface topography, and pachymetry of normal human eyes

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Michele Lagana · Bausch & Lomb Incorporated

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2006-09-30
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347594 on ClinicalTrials.gov